RxSight, Inc. (RXST)
4.895
+0.06
(+1.35%)
USD |
NASDAQ |
Nov 18, 10:49
RxSight Debt to Equity Ratio : 0.0405 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0405 |
| June 30, 2026 | 0.0402 |
| March 31, 2026 | 0.0405 |
| December 31, 2025 | 0.04 |
| September 30, 2025 | 0.0419 |
| June 30, 2025 | 0.0421 |
| March 31, 2025 | 0.0431 |
| December 31, 2024 | 0.0437 |
| September 30, 2024 | 0.0408 |
| June 30, 2024 | 0.0415 |
| March 31, 2024 | 0.0154 |
| December 31, 2023 | 0.0188 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.0206 |
| June 30, 2023 | 0.1489 |
| March 31, 2023 | 0.3077 |
| December 31, 2022 | 0.5005 |
| September 30, 2022 | 0.4724 |
| June 30, 2022 | 0.4144 |
| March 31, 2022 | 0.3646 |
| December 31, 2021 | 0.325 |
| September 30, 2021 | 0.2991 |
| June 30, 2021 | 1.124 |
| March 31, 2021 | 0.6803 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Precision Optics Corp., Inc. | 0.1898 |
| Globus Medical, Inc. | 0.0226 |
| Abbott Laboratories | 0.6106 |
| Align Technology, Inc. | 0.034 |
| AngioDynamics, Inc. | 0.0655 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 340.42M |
| Total Liabilities (Quarterly) | 85.51M |
| Shareholders Equity (Quarterly) | 254.91M |
| Current Ratio | 4.200 |
| Net Debt Paydown Yield | 0.14% |